Home Business News Pharma retail market bounces back to robust growth in December - Times...

Pharma retail market bounces back to robust growth in December – Times of India


MUMBAI: Domestic pharma retail market bounced back with a substantial growth of 8.4% y-o-y (year-on-year) in December, after a weak performance during the year, led by a higher number of prescriptions, OPD (outpatient department) visits, and increased marketing push by drug companies.
During 2020, October was the lone month which posted a robust growth of nearly 10%, while the market dipped to 1% growth in November.
The acute segment (45% of market) grew 6% y-o-y while chronic (55%) rose nearly 11% y-o-y in the month.
Overall, the high-margin chronic segment will continue to do well compared to the low-margin acute segment, due to the longer duration of diseases, changes in lifestyle and poor food habits coupled with an increasing disposable income, according to India Ratings and Research (Ind-Ra).
The growth was led by volume growth of 0.3% y-o-y (November: negative 6.9% y-o-y), price growth of 5% (4.7%) and new launches growth of 3.1% (3.2%).
As the number of prescriptions dispensed has increased, acute therapy sales grew by 6% during December. Also, healthy traction was witnessed in chronic therapies. On a moving annual total (MAT) basis, revenue in acute therapies was almost flat, while that in the chronic and sub-chronic therapies grew 8.5% and 2.8% y-o-y, respectively.
Acute therapies such as vitamins, gastro and derma witnessed growth of 14%, 16.2% and 10.8% y-o-y, respectively, during the month, while a growth outperformance was observed in chronic therapies with cardiac, anti-diabetic and CNS growing 14.9%, 9.9% and 9.2% y-o-y, respectively.
Ind-Ra highlights the sharp sales growth recovery seen in December in therapies such as anti-infectives to 5.2% (0.2% in November), analgesic at 6% (negative 5.2%), gynaec at 6.6% (negative 4.3%), and anti-neoplastic at 8.1% (0.1%).
During December, Glenmark, Aristo, Cipla and Torrent were among the top performers, and significantly outperformed the market, with y-o-y growth of 16.1%, 9%, 8.2%, and 6.9%, respectively. This was led by higher sales of Covid-19- related products, and the continued outperformance of chronic therapies.



Source link

Avatar
Sahilhttp://digitalguruji.org
In this blog our main motive is to provide you all kind of latest information about technology, politics, sports, and health. If you want to read this information then you should have to visit our website. This information will help you to increase your knowledge.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

JustDial co-founder Ramani Iyer builds smartphone power bank rental network – Times of India

Justdial’s co-founder Ramani Iyer has launched his latest venture ‘Spykke’, a smartphone power bank rental service. In 6 months,

Government makes dual airbags mandatory for cars – Times of India

NEW DELHI: The government on Friday announced its decision to make the passenger side airbag mandatory in new cars....

No winners: UK waits for Harry, Meghan’s take on royal split – Times of India

LONDON: The timing couldn't be worse for Harry and Meghan. The Duke and Duchess of Sussex will finally get the chance...

Weight loss story: “Boiled eggs and salads helped me lose 37 kilos in less than a year” | The Times of India

Devastated by a shopping trip when no clothes would fit him, Prabal realized his lockdown weight gain had gone extremely out of hand....

Recent Comments